Release Date: 12/05/20 09:03 Summary: CSR Limited Review of Results -full year ended 31 March 2020 Price Sensitive: Yes Download Document 128.64KB Download
PTX This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution